SOD1 and metabolic dysfunction-associated steatotic liver disease: In the quest to capitalize on the role of oxidative stress in NAFLD progression, clinical studies identified that the serum level of malondialdehyde (MDA) [132] is increased in NAFLD, as this highlights that lipid peroxidation represents a marked process and, more than that, a decrease in the levels of antioxidants such as Coenzyme Q10 (CoQ10) and CuZn-superoxide dismutase (SOD) [133].